{
  "issued_date": "2009-04-29", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON044110", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2009/032", 
    "Audience": "Healthcare professionals", 
    "Published": "29 April 2009 at 14:30", 
    "Format": "Electronic", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [], 
  "body": "## Device\n\nBioprosthetic heart valves.\n\nAll makes and models.\n\n## Problem\n\nEarly valve revision with associated morbidity or mortality risks if these valves are not adequately washed or rinsed prior to implantation.\n\nResidues of chemicals typically used in the storage of bioprosthetic heart valves can adversely affect the patient\u2019s annular tissue and lead to premature failure of the valve.\n\nThe MHRA has been investigating a small number of serious adverse incidents, including patient deaths, due to premature failure of bioprosthetic heart valves. Our findings have highlighted the importance of precisely following the manufacturer\u2019s instructions on thorough pre-implantation valve washing or rinsing.\n\nEach model of valve is supplied with the manufacturer\u2019s specific instructions for use (IFU). Users should be aware that the requirements for valve preparation can vary significantly between models\u00a0\\- in particular, the rinsing times and number of water baths required. Users should therefore ensure that they are familiar with the instructions specific to the valve that they intend to implant.\n\nBioprosthetic replacement heart valves have been available for many years. It is common practice for these valves to be stored in a low concentration of aldehyde solution, which acts to protect and preserve the valve during its transport and storage. These solutions can be toxic to the body. It is therefore essential that any residual solution is removed prior to implantation. Since the valve will be sewn into the patient\u2019s native annulus, failure to adequately rinse off these toxic chemicals is likely to adversely affect annular healing. This may give rise to an abscess or necrosis around the valve and/or endocarditis-like syndromes (without positive microbiological cultures) presenting at an unpredictable period of time after implantation.\n\n## Action  \n  \n  * Accurately follow the manufacturer\u2019s instructions for use (IFU) on valve preparation prior to its implantation.  \n  * Ensure that all relevant members of the surgical team are familiar with the manufacturer\u2019s instructions on valve washing or rinsing, specific to each valve model.  \n  \n## Distribution\n\nThis MDA has been distributed to:  \n  \n  * NHS trusts in England (Chief Executives)  \n  * Care Quality Commission (CQC) (Headquarters)  \n  * HSC Trusts in Northern Ireland (Chief Executives)  \n  * NHS Boards in Scotland (Chief Executives)  \n  \nOnward distribution  \nPlease bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:\n\nTrusts to:  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * Cardiologists  \n  * Cardiothoracic surgeons  \n  * Clinical governance leads  \n  * Clinical pathologists  \n  * Clinical pathology directors  \n  * Medical directors  \n  * Radiologists  \n  * Radiology departments  \n  * Risk managers  \n  * Theatre managers  \n  * Theatre nurses  \n  \nCare Quality Commission (CQC) (England only) to:  \nHeadquarters for onward distribution as appropriate to:  \n  \n  * Hospitals in the independent sector  \n  * Private medical practitioners  \n  \nChange of address or removal from address list for Care Quality Commission:  \nNational Contact Centre  \nCare Quality Commission  \nSt Nicholas Building  \nSt Nicholas Street  \nNewcastle-upon-Tyne  \nNE1 1NB\n\nTel: 03000 61 61 61\n\nE-mail: [enquiries@cqc.org.uk](mailto:enquiries@cqc.org.uk)\n\n## Manufacturer Contact\n\nThis MDA applies to all bioprostheitc heart valves. Contact the relevant manufacturer. \n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2009/032 or 2008/008/029/401/005\n\nTechnical aspects  \nAlexander McLaren or Elen Shute  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers  \n1 Nine Elms Lane  \nLondon SW8 5NQ\n\nTel: 020 7084 3292 / 3281  \nFax: 020 7084 3106  \nE-mail:  \n[alexander.mclaren@mhra.gsi.gov.uk](mailto:alexander.mclaren@mhra.gsi.gov.uk)  \n[elen.shute@mhra.gsi.gov.uk](mailto:elen.shute@mhra.gsi.gov.uk)\n\nClinical aspects  \nDr Christopher Brittain  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers  \n1 Nine Elms Lane  \nLondon SW8 5NQ\n\nTel: 020 7084 3126  \nFax: 020 7084 3111  \nE-mail: [christopher.brittain@mhra.gsi.gov.uk](mailto:christopher.brittain@mhra.gsi.gov.uk)\n\nHow to report adverse incidents  \nPlease report via our website <http://www.mhra.gov.uk>  \nFurther information about CAS can be found at <https://www.cas.dh.gov.uk/Home.aspx>\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.  \nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre (NIAIC)  \nHealth Estates  \nEstate Policy Directorate  \nStoney Road  \nDundonald  \nBelfast  \nBT16 1US\n\nTel: 02890 523 704  \nFax: 02890 523 900\n\nE-mail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n<http://www.dhsspsni.gov.uk/index/hea/niaic.htm>\n\nHow to report adverse incidents in Northern Ireland  \nPlease report directly to NIAIC, further information can be found on our website <http://www.dhsspsni.gov.uk/niaic>  \nFurther information about SABS can be found at <https://sabs.dhsspsni.gov.uk>\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh  \nEH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nE-mail: [iric@shs.csa.scot.nhs.uk](mailto:iric@shs.csa.scot.nhs.uk)  \n<http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/>\n\n## Wales\n\nEnquiries in Wales should be addressed to:\n\nDr Jane Ludlow  \nSenior Medical Officer  \nMedical Device Alerts  \nWelsh Assembly Government  \nCathays Park  \nCardiff  \nCF10 3NQ\n\nTel: 029 2082 3505 / 3922\n\nE-mail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p>Bioprosthetic heart valves.</p><p>All makes and models.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>Early valve revision with associated morbidity or mortality risks if these valves are not adequately washed or rinsed prior to implantation.</span></p><p><span>Residues of chemicals typically used in the storage of bioprosthetic heart valves can adversely affect the patient&#8217;s annular tissue and lead to premature failure of the valve.</span></p><p>The MHRA has been investigating a small number of serious adverse incidents, including patient deaths, due to premature failure of bioprosthetic heart valves. Our findings have highlighted the importance of precisely following the manufacturer&#8217;s instructions on thorough pre-implantation valve washing or rinsing.</p><p>Each model of valve is supplied with the manufacturer&#8217;s specific instructions for use (IFU). Users should be aware that the requirements for valve preparation can vary significantly between models&#160;- in particular, the rinsing times and number of water baths required. Users should therefore ensure that they are familiar with the instructions specific to the valve that they intend to implant.</p><p>Bioprosthetic replacement heart valves have been available for many years. It is common practice for these valves to be stored in a low concentration of aldehyde solution, which acts to protect and preserve the valve during its transport and storage. These solutions can be toxic to the body. It is therefore essential that any residual solution is removed prior to implantation. Since the valve will be sewn into the patient&#8217;s native annulus, failure to adequately rinse off these toxic chemicals is likely to adversely affect annular healing. This may give rise to an abscess or necrosis around the valve and/or endocarditis-like syndromes (without positive microbiological cultures) presenting at an unpredictable period of time after implantation.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<ul>\r\n\t\t\t\t<li>Accurately follow the manufacturer&#8217;s instructions for use (IFU) on valve preparation prior to its implantation.</li>\r\n\t\t\t\t<li>Ensure that all relevant members of the surgical team are familiar with the manufacturer&#8217;s instructions on valve washing or rinsing, specific to each valve model.</li></ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been distributed to:</p><ul>\r\n\t\t\t\t<li>NHS trusts in England (Chief Executives)</li>\r\n\t\t\t\t<li>Care Quality Commission (CQC) (Headquarters)</li>\r\n\t\t\t\t<li>HSC Trusts in Northern Ireland (Chief Executives)</li>\r\n\t\t\t\t<li>NHS Boards in Scotland (Chief Executives)</li></ul><p><font class=\"h4\">Onward distribution</font><br>Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:</p><p><font class=\"h4\">Trusts to:</font><br>CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p><ul>\r\n\t\t\t\t<li>Cardiologists</li>\r\n\t\t\t\t<li>Cardiothoracic surgeons</li>\r\n\t\t\t\t<li>Clinical governance leads</li>\r\n\t\t\t\t<li>Clinical pathologists</li>\r\n\t\t\t\t<li>Clinical pathology directors</li>\r\n\t\t\t\t<li>Medical directors</li>\r\n\t\t\t\t<li>Radiologists</li>\r\n\t\t\t\t<li>Radiology departments</li>\r\n\t\t\t\t<li>Risk managers</li>\r\n\t\t\t\t<li>Theatre managers</li>\r\n\t\t\t\t<li>Theatre nurses</li></ul><p><font class=\"h4\">Care Quality Commission (CQC) (England only) to:<br></font> Headquarters for onward distribution as appropriate to:</p><ul>\r\n\t\t\t\t<li>Hospitals in the independent sector</li>\r\n\t\t\t\t<li>Private medical practitioners</li></ul><p><font class=\"h4\">Change of address or removal from address list for Care Quality Commission:</font><br>National Contact Centre<br>Care Quality Commission<br>St Nicholas Building<br>St Nicholas Street<br>Newcastle-upon-Tyne<br>NE1 1NB</p><p>Tel: 03000 61 61 61</p><p>E-mail: <a href=\"mailto:enquiries@cqc.org.uk\">enquiries@cqc.org.uk</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\tThis MDA applies to all bioprostheitc heart valves. Contact the relevant manufacturer.\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2009/032</span> or <span>2008/008/029/401/005</span></p><p><span>Technical aspects</span><br>Alexander McLaren or Elen Shute<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers<br>1 Nine Elms Lane<br>London SW8 5NQ</p><p>Tel: 020 7084 3292 / 3281<br>Fax: 020 7084 3106<br>E-mail:<br><a href=\"mailto:alexander.mclaren@mhra.gsi.gov.uk\">alexander.mclaren@mhra.gsi.gov.uk</a><br><a href=\"mailto:elen.shute@mhra.gsi.gov.uk\">elen.shute@mhra.gsi.gov.uk</a></p><p><span>Clinical aspects</span><br>Dr Christopher Brittain<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers<br>1 Nine Elms Lane<br>London SW8 5NQ</p><p>Tel: 020 7084 3126<br>Fax: 020 7084 3111<br>E-mail: <a href=\"mailto:christopher.brittain@mhra.gsi.gov.uk\">christopher.brittain@mhra.gsi.gov.uk</a></p><p><span>How to report adverse incidents</span><br>Please report via our website <a href=\"http://www.mhra.gov.uk\">http://www.mhra.gov.uk</a><br>Further information about CAS can be found at <a href=\"https://www.cas.dh.gov.uk/Home.aspx\">https://www.cas.dh.gov.uk/Home.aspx</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.<br>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p><p>Northern Ireland Adverse Incident Centre (NIAIC)<br>Health Estates<br>Estate Policy Directorate<br>Stoney Road<br>Dundonald<br>Belfast<br>BT16 1US</p><p>Tel: 02890 523 704<br>Fax: 02890 523 900</p><p>E-mail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\">NIAIC@dhsspsni.gov.uk</a></p><p><a href=\"http://www.dhsspsni.gov.uk/index/hea/niaic.htm\">http://www.dhsspsni.gov.uk/index/hea/niaic.htm</a></p><p><span>How to report adverse incidents in Northern Ireland</span><br>Please report directly to NIAIC, further information can be found on our website <a href=\"http://www.dhsspsni.gov.uk/niaic\">http://www.dhsspsni.gov.uk/niaic</a><br>Further information about SABS can be found at <a href=\"https://sabs.dhsspsni.gov.uk\">https://sabs.dhsspsni.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p><p>Incident Reporting and Investigation Centre<br>Health Facilities Scotland<br>NHS National Services Scotland<br>Gyle Square<br>1 South Gyle Crescent<br>Edinburgh<br>EH12 9EB</p><p>Tel: 0131 275 7575<br>Fax: 0131 314 0722</p><p>E-mail: <a href=\"mailto:iric@shs.csa.scot.nhs.uk\">iric@shs.csa.scot.nhs.uk</a><br><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\">http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:</p><p>Dr Jane Ludlow<br>Senior Medical Officer<br>Medical Device Alerts<br>Welsh Assembly Government<br>Cathays Park<br>Cardiff<br>CF10 3NQ</p><p>Tel: 029 2082 3505 / 3922</p><p>E-mail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Bioprosthetic heart valves. All makes and models (MDA/2009/032)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}